Inactive Instrument

Highlights Spotlight Innovation Inc. Other OTC

Equities

STLT

US8492071050

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Spotlight Innovation Enters into Research Agreement with Indiana University	17-08-17	CI
Spotlight Innovation Inc. Enters into Sponsored Research Agreement with The Brigham and Women's Hospital Inc	17-06-27	CI
Spotlight Innovation Licenses Additional Anti-Zika Virus Compounds	17-02-15	CI
Spotlight Innovation Inc. Enters into a Second Exclusive License Agreement with Florida State University Research Foundation	17-01-31	CI
Spotlight Innovation Announces Strategic Investment in Solx, Inc	16-11-30	CI
Spotlight Innovation Inc. Enters into Exclusive License Agreement with Florida State University Research Foundation	16-11-10	CI
Spotlight Innovation Inc. Enters into License Agreement with Indiana University Research and Technology Corporation	16-10-17	CI
Spotlight Innovation Inc. Establishes Subsidiary as Caretta Therapeutics	16-10-06	CI
Spotlight Innovation Inc. Enters into Sponsored Research Agreement with Florida State University	16-09-26	CI
Spotlight Innovation Inc. Enters into an Agreement with Maitland Labs to Establish its Drug Production and Product Development Facilities	16-06-10	CI
Spotlight Innovation Inc. Enters into Research Agreement with University of Alabama At Birmingham	16-03-16	CI
Spotlight Innovation : Engages DAK Capital to Provide Merger and Acquisition Advisory Services	15-07-16	MW
Spotlight Innovation, Inc. completed the acquisition of 82.3% stake in Memcine Pharmaceuticals Inc.	15-06-02	CI
Spotlight Innovation Seeks Acquisitions	15-04-28	CI
Celtic Biotech Iowa Licenses Promising Therapy for Chronic Kidney Disease	15-03-10	CI
Spotlight Innovation, Inc. signed a letter of intent to acquire a majority stake Memcine Pharmaceuticals Inc.	14-10-14	CI
Spotlight Innovation, Inc. completed the acquisition of 95% stake in Celtic Biotech Ltd.	14-06-30	CI
Celtic Biotech Iowa, Inc. Enters into an Exclusive License Agreement with Celtic Biotech Limited	14-03-14	CI
Spotlight Innovation LLC completed the acquisition of American Exploration Corporation (OTCPK: AEXP) in a reverse merger transaction.	13-12-09	CI
American Exploration Corporation (OTCPK: AEXP) entered into a letter of intent to acquire 90% stake in Celtic Biotech Ltd.	13-10-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Spotlight Innovation Inc. Other OTC

Equities

STLT

US8492071050

Highlights

Filters